REQUEST A DEMO
Total
USD $0.00
Search more companies

Imporclinicos Limitada (Colombia)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Imporclinicos Limitada Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Imporclinicos Limitada is based in Colombia, with the head office in Bucaramanga. It operates in the Medical Equipment and Supplies Manufacturing industry. It was first established on June 18, 2003. Imporclinicos Limitada currently employs 14 (2024) people. There was a net sales revenue increase of 53.17% reported in Imporclinicos Limitada’s latest financial highlights for 2023. Its total assets grew by 24.05% over the same period. In, 2023, the company’s net profit margin decreased by 3.54%.

Headquarters
Calle 32 29 41
Bucaramanga; Santander;

Contact Details: Purchase the Imporclinicos Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Imporclinicos Limitada report to view the information.
Outstanding Shares:
Purchase the Imporclinicos Limitada report to view the information.
Incorporation Date:
June 18, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Imporclinicos Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
53.17%
Total operating revenue
52.85%
Operating profit (EBIT)
-24.38%
EBITDA
-52.37%
Net Profit (Loss) for the Period
-24.22%
Total assets
24.05%
Total equity
11.55%
Operating Profit Margin (ROS)
-5.17%
Net Profit Margin
-3.54%
Return on Equity (ROE)
-4.89%
Debt to Equity Ratio
0.95%
Quick Ratio
-0.95%
Cash Ratio
-0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?